Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.

Xpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert under routine conditions in settings with high TB burden.A pragmatic prospective cluster-randomised trial of Xpert for all individuals with presumptive (sympto...

Full description

Bibliographic Details
Main Authors: Helen S Cox, Slindile Mbhele, Neisha Mohess, Andrew Whitelaw, Odelia Muller, Widaad Zemanay, Francesca Little, Virginia Azevedo, John Simpson, Catharina C Boehme, Mark P Nicol
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-11-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC4244039?pdf=render

Internet

http://europepmc.org/articles/PMC4244039?pdf=render

Similar Items